Get all premium features to the best stock analysis tool

Trupanion, Inc. (TRUP) Q1 2026 Earnings Call Transcript

Although the revenue and EPS for Trupanion (TRUP) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

SEATTLE, April 27, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, has published its 2025 annual shareholder letter from CEO and President, Margi Tooth. The letter is now available on the Company's Investor Relations website here.

Trupanion (TRUP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SEATTLE, April 16, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2026 first quarter after the market closes on Thursday, April 30, 2026. The company will host a conference call that day beginning shortly after 1:30 p.m.

2,837 shares sold on Feb. 27, 2026 at a weighted average price of $26.46 per share, totaling approximately ~$75,000 in transaction value. This sale represented 100.00% of Qureshi's direct holdings, reducing direct and indirect ownership of common stock to zero after the transaction.

Trupanion is upgraded to Buy after achieving its first GAAP profit and demonstrating improved financial resilience. Gross margins rose from 12% to 16% (2023–2025), with operating leverage and scalable digital operations supporting sustainable free cash flow growth. TRUP targets 14% subscription revenue growth in 2026, with U.S. pet insurance penetration under 4% and significant runway for expansion.